Asset Details
Do you wish to reserve the book?
Saving babies and families from preventable harm: a review of the current state of fetoplacental monitoring and emerging opportunities
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Saving babies and families from preventable harm: a review of the current state of fetoplacental monitoring and emerging opportunities
Do you wish to request the book?
Saving babies and families from preventable harm: a review of the current state of fetoplacental monitoring and emerging opportunities
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Saving babies and families from preventable harm: a review of the current state of fetoplacental monitoring and emerging opportunities
2024
Overview
Neonatal outcomes have improved over the last decade following significant thrust in this area, but stillbirth, preterm birth and neonatal brain injury remain acute global problems with long-lasting parental and family psychological trauma. In 2020, 1 in every 225 pregnancies in UK ended in stillbirth, with 2 million stillbirths reported worldwide. Over 40% of all stillbirths occur during labor—a loss that could be avoided with improved fetal monitoring and timely access to emergency obstetric care when required. Nearly one-fourth of global neonatal mortality relates to intrapartum-related events. Currently, available monitoring tools rely on surrogate markers such as serial fetal size measurement, doppler assessment of fetoplacental perfusion, fetal heart rate variability, fetal movements and maternal circulating placental proteins to identify the vulnerable fetus. Continuous cardiotocography (CTG) is the current standard of monitoring for fetal assessment in labor, but a Cochrane review indicated that it failed to significantly reduce poor outcomes in newborn infants, and resulted in an increase in the number of Caesarean sections. There is an urgent need for the development of a monitoring platform to directly measure acute or chronic changes related to fetoplacental compromise which can be operated with ease both in the hospital and remotely in the home environment in high-risk pregnancies. In recent years, there has been some promising development to identify compromised fetuses using advanced technologies and artificial intelligence-based approaches. We present here the current state of fetoplacental monitoring, focussing primarily on antepartum monitoring and discuss a possible way forward using digital biomarkers in this area to protect babies and mothers in future.
